Author Details

Frank, G A

Issue Section Title File
Vol 9, No 2 (2007) Articles Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Vol 11, No 2 (2009) Articles Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Vol 15, No 2 (2013) Articles Prognostic value of p53 expression in patients with stage I breast cancer
Vol 16, No 2 (2014) Articles The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Vol 16, No 4 (2014) Articles Tumor biology or adjuvant systemic therapy: what determines the risk of recurrence in breast cancer stage I?
Vol 17, No 1 (2015) Articles Immunological heterogeneity of stage I breast cancer:biological, population-based and prognostic value (international cooperation experience)
Vol 17, No 2 (2015) Articles The role and assessment of morphological regression after neoadjuvant therapy in breast cancer patients
Vol 17, No 3 (2015) Articles The results of Epidemiological HER2 screening program in patients with breast cancer in 2014
Vol 18, No 3 (2016) Articles The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015 PDF
(Rus)
Vol 14, No 1 (2012) Articles Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie)
Vol 14, No 1 (2012) Articles HER2-testirovanie metodamiimmunogistokhimii, fluorestsentnoy(FISH) i khromogennoy (SISH) in situgibridizatsii pri rake zheludkai pishchevodno-zheludochnogo perekhoda
Vol 20, No 4 (2018) Articles Quality control of immunohistochemical analyzes in Russia: yesterday, today, tomorrow PDF
(Rus)

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies